Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Home › News
📰 All News

Life Science & Pharma News

The latest pharmaceutical, biotechnology, MedTech, and healthcare news and analysis from Ireland, the EU, and globally.

224
Articles
19
Pages
IE
Ireland first
How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions
MedTech
How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions
Middle managers stall more AI rollouts than bad technology does. Here are the 5 root causes of that resistance and the interventions that convert it to active advocacy within 90 days-specifically tailored for Ireland’s thriving Pharmaceutical and MedTech sectors.
Sreepriya Prasannan
Sreepriya Prasannan
25 Jun 2026 · 6 min
Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland
Industry
Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland
An in-depth look at WorkEqual, its mission to help women (re)enter the Irish workforce, its national advocacy for gender parity, and the new WorkAbility Programme supporting people with disabilities.
Sreepriya Prasannan
Sreepriya Prasannan
23 Jun 2026 · 4 min
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
Biotechnology
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.
Sreepriya Prasannan
Sreepriya Prasannan
23 Jun 2026 · 5 min
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
Sreepriya Prasannan
Sreepriya Prasannan
23 Jun 2026 · 4 min
Scaling Ireland’s Biopharma Leadership: Inside Eli Lilly’s $2.8 Billion Manufacturing Expansion in Limerick and Kinsale
Pharmaceutical
Scaling Ireland’s Biopharma Leadership: Inside Eli Lilly’s $2.8 Billion Manufacturing Expansion in Limerick and Kinsale
An in-depth analysis of Eli Lilly’s massive manufacturing footprint in Limerick and Kinsale, highlighting local jobs, high-tech biologic drug production, and Ireland’s strategic position in the global biopharma supply chain.
Sreepriya Prasannan
Sreepriya Prasannan
23 Jun 2026 · 4 min
Roche Seeks Buyer for Former Manufacturing Site in Clarecastle, Co Clare - €4m Price Tag
Pharmaceutical
Roche Seeks Buyer for Former Manufacturing Site in Clarecastle, Co Clare - €4m Price Tag
Swiss pharma giant Roche has appointed Cushman & Wakefield to sell its 88-acre decommissioned manufacturing facility in Clarecastle, Co Clare, with an expected asking price of €4 million, following a €150m remediation programme.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 4 min
Ireland Tightens Family Reunification Rules: Higher Income Thresholds, Housing Checks and Stricter Relationship Scrutiny
Industry
Ireland Tightens Family Reunification Rules: Higher Income Thresholds, Housing Checks and Stricter Relationship Scrutiny
The Irish Department of Justice has overhauled its family reunification framework, raising the income requirement for Irish citizen sponsors to €75,000 over three years, introducing housing sufficiency checks, and imposing a new two-year waiting period for refugees. Here is everything migrants and families in Ireland need to know.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 7 min
Status Yellow High Temperature Warning Issued for Ireland - Your Complete Health & Safety Guide
Pharmaceutical
Status Yellow High Temperature Warning Issued for Ireland - Your Complete Health & Safety Guide
Met Éireann has issued a Status Yellow High Temperature Warning for Ireland. Here is everything you need to know: how to protect yourself and your family, what to eat and drink, what to keep at home, and the key precautions recommended by HSE and public health experts.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 8 min
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
LinkedIn
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 17 min
How to Build a Powerful Personal Brand in Pharma Without Sharing Proprietary Data
Regulatory Affairs
How to Build a Powerful Personal Brand in Pharma Without Sharing Proprietary Data
A complete step-by-step guide for pharmaceutical, biotech and life science professionals on building a credible, visible personal brand on LinkedIn - without ever crossing compliance lines or risking proprietary data exposure. Covers brand strategy, content pillars, storytelling frameworks, and the exact boundaries every pharma professional must respect.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 9 min
How to Highlight Regulatory Affairs and Compliance Expertise on Your LinkedIn Profile
LinkedIn
How to Highlight Regulatory Affairs and Compliance Expertise on Your LinkedIn Profile
A detailed step-by-step LinkedIn guide for Regulatory Affairs Specialists, Quality Assurance professionals, Pharmacovigilance Officers, CMC Scientists, and all pharmaceutical compliance professionals. Learn exactly how to frame your regulatory expertise on LinkedIn to attract the right roles, visibility, and recognition - without exposing proprietary submissions or confidential regulatory strategy.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 13 min
U.S. Initiates Tariff Probe into Germany’s Pharmaceutical Pricing Policies
Industry
U.S. Initiates Tariff Probe into Germany’s Pharmaceutical Pricing Policies
The United States has formally launched a trade investigation under Section 301 into Germany’s drug reimbursement practices, citing concerns that domestic price controls unfairly burden American innovation.
Sreepriya Prasannan
Sreepriya Prasannan
22 Jun 2026 · 4 min